Cero Therapeutics Holdings, Inc.
CERO- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCEROW
Q4 2024 vs. Q3 2024
How the institutions holding Cero Therapeutics Holdings, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 18 | 21 | +3 |
| Shares | 3.44M | 13.3M | +9.90M (+287.7%) |
| Value | $320.0K | $800.3K | +$480.2K (+150.1%) |
New holders (11)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cubist Systematic Strategies, LLC | 333,442 | $20.0K | 0.00% |
| JustInvest LLC | 234,657 | $14.1K | 0.00% |
| Cantor Fitzgerald, L. P. | 155,000 | $10.0K | 0.00% |
| Goldman Sachs Group Inc | 162,474 | $9.75K | 0.00% |
| Millennium Management LLC | 63,054 | $3.78K | 0.00% |
| SG Americas Securities, LLC | 25,752 | $2.00K | 0.00% |
| Revolve Wealth Partners, LLC | 32,799 | $1.97K | 0.00% |
| HBK Sorce Advisory LLC | 26,249 | $1.57K | 0.00% |
| Guidance Point Advisors, LLC | 18,717 | $1.12K | 0.00% |
| Marex Group plc | 15,000 | $900 | 0.00% |
| SBI Securities Co., Ltd. | 5,523 | $331 | 0.00% |
Sold out (8)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Geode Capital Management, LLC | 157,445 | $14.7K |
| HRT Financial LP | 79,562 | $7.00K |
| Fifth Lane Capital, LP | 76,593 | $6.89K |
| XTX Topco Ltd | 56,532 | $5.27K |
| StoneX Group Inc. | 16,600 | $1.55K |
| CI Private Wealth, LLC | 14,999 | $1.40K |
| Jump Financial, LLC | 11,948 | $1.11K |
| Pineridge Advisors LLC | 300 | $28 |